POS1549 BETTER DRUG SURVIVAL ON MONOCLONAL ANTIBODIES COMPARED TO ETANERCEPT IN FIRST LINE ANTI-TNF THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS MAY BE DUE TO DIFFERENTIAL THERAPEUTIC RESPONSE IN SKIN INVOLVEMENT: A PROPENSITY SCORE-MATCHED ANALYSIS FROM THE NATIONWIDE CZECH ATTRA REGISTRY